NONCLASSICAL ANTIMETABOLITES. XV. BRIDGE PRINCIPLE OF SPECIFICITY WITH ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITORS. VI. HIGHLY SELECTIVE IRREVERSIBLE INHIBITION OF LACTIC DEHYDROGENASE.
D000963:Antimetabolites; D004791:Enzyme Inhibitors; D007770:L-Lactate Dehydrogenase; D009132:Muscles; D009206:Myocardium; D010088:Oxidoreductases; D010600:Pharmacology; D012106:Research; D012459:Salicylates
D000963:Antimetabolites; D004791:Enzyme Inhibitors; D012459:Salicylates; D010088:Oxidoreductases; D007770:L-Lactate Dehydrogenase
ANTIMETABOLITES; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; LACTATE DEHYDROGENASE; MUSCLES; MYOCARDIUM; PHARMACOLOGY; SALICYLATES